| Skip to Content |
| Unit for corneal diseases and the previous sector |
| || || |
| || || |
| || |
1. The impact of the travaprost in keratometry and corneal hysteresis in patients with pre-keratoconus.
To determine the degree in which the travaprost 0.004% can reduce the keratometry in patients with pre-keratoconus.
To analyse if a correlation exists between the degree of reduction of the keratometry and the degree of reduction of the PIO in these patients.
To study if the travaprost 0.004% modifies the corneal hysteresis in patients with ectasia.
2. Influence of glare in healthy patients.
We sought to establish the normality parameters relating to glare of healthy subjects, in order to be able to subsequently analyze which factors affect them, among which are:
Age of the Subject
Once the analysis is completed, the information obtained will be used in order to be able to analyse problems derived from discomfort due to the light, which refers to patients who have been implanted with an intraocular lens or who have been involved in refractive surgery in future studies.
3. Evaluation of the stability and aberrations produced in the rotation of toric lenses to do with cataracts operation patients.
To evaluate the stability of the toric lenses once they are inserted and study the effects that the rotations produce for the visual quality of the patient.
To analyse the possible surgical problems at the time of the implantation and evaluation of the intraocular lens rotation.
To determine the residual astigmatism that the lens is not capable of fixing.
4. Pterygium: refractive aberrometry modification, after surgery.
The purpose of this study is to analyse the aberrometric and refractive changes that the patient experiences after the Pterygium surgery.
5. Pterygium: role of oxidative stress
6. Pterygium: role of vascular endothelial growth factor and its suppression in post-surgical recurrence of pterygium
The aim of this study is to analyse the role of the anti-angiogenics in the recurrence of pterygium.
| || || |